NSEGeneral Updates2d ago · 4 Nov 2026, 04:29 pm
General Updates
Dabur India Limited · DABUR
✦ AI SummaryResults
Dabur India Limited has informed the Exchange about Investor Presentation for Quarter Ended September 2026, highlighting sequential improvement in topline growth, revenue, operating profit, and PAT.
Analysis Scores
Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dabur India Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
DABURA_04112026162930_presentation.pdf
View document text
'DaDur
India ltd.
Ref: SEC/SE/2026-27
Date: November 04, 2026
Corporate Relations Department Listing Department
BSE Ltd. National Stock Exchange of India Ltd.
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor
Dalal Street, Plot No. C/1, G Block, Sandra Kurla Complex
Mumbai- 400001 Sandra (E), Mumbai - 400051
SSE Scrip Code: 500096 NSE Scrip Symbol: DABUR
Sub: Investor Presentation
Dear Sir/Madam,
In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we are enclosing herewith copy of investor presentation being issued today i.e.,
November 04, 2026.
This is for your information and records.
Thanking You,
Yours faithfully,
For Dabur India Limited
~arJaln)
Group Company Secretary and Chief Compliance Officer
Encl.: as above
DABUR INDIA LIMITED, Punjabi Bhawan, 10, Rouse Avenue, New Delhi-110 002, Tel.: +91 11 71206000
Re~d. Office: 8/3, Asaf Ali Road, New Delhi -110 002 (India)
, CIN: L24230DL1975PLC007908, Email: corpcomm@dabur.com, Website: www.dabur.com
DABUR INDIA LIMITED
INVESTOR
PRESENTATION
For Quarter Ended September 2026
Contents
1 Quarterly
3 Brand
Snapshot
Communication
2 Performance 4 Annexures
Highlights
DISCLAIMER
Cautionary note concerning forward-looking statement
Certain statements made in this presentation relating to the Company’s objectives, projections, outlook, expectations, estimates, among others may constitute
‘forward-looking statements’ within the meaning of applicable laws and regulations. Actual results may differ from such expectations, projections etc., whether
express or implied. These forward-looking statements are based on various assumptions, expectations and other factors which are not limited to, risk and
uncertainties regarding fluctuations in earnings, competitive intensity, pricing environment in the market, economic conditions affecting demand and supply,
change in input costs, ability to maintain and manage key customer relationships and supply chain sources, new or changed priorities of trade, significant changes
in political stability in India and globally, government regulations and taxation, climatic conditions, natural calamity, commodity price fluctuations, currency rate
fluctuations, litigation among others over which the Company does not have any direct control. The company cannot, therefore, guarantee that the ‘forward-
looking’ statements made herein shall be realized. The Company, may alter, amend, modify or make necessary corrective changes in any manner to any such
forward looking statement contained herein or make written or oral forward-looking statements as may be required from time to time based on subsequent
developments and events.
01 Quarterly
Snapshot
NO ADDED SUGARS NO ADDED PRESERVATIVES
Quarter Highlights
Sequential Improvement in topline growth
Revenue Operating Profit PAT
Consolidated INR 3,563 Cr INR 633 Cr INR 505 Cr
Growth 11.6% Growth 7.5% (-60 bps) Growth 11.7%
Operating Profit
Revenue PAT
INR 459 Cr
INR 2,433 Cr INR 388 Cr
Standalone
Growth 8.2% (-10 bps) Growth 11.2%
Growth 8.9%
Revenue
Revenue
Growth 10.7% International
India FMCG Growth 20.0%
Volume 5.5%
Note: The india map is for illustrative purposes only, is not drawn to scale, and does not represent the accuracy or authenticity of geographical or political boundaries
Industry Outlook
Strong Fundamentals, Sustainable Growth
Geopolitical Tensions Stable Demand
Elevated Inflation
Persistent inflationary Renewed US-Iran conflict Domestic demand
pressures across various leading to volatile remained resilient.
commodities. operating environment.
02 Performance
Highlights
Business Segment Performance
24% 55%
Healthcare
623 Cr. 1,385 Cr.
5.5% 12.3%
Growth Growth
Oral Care
Hair Care
Home &
Personal Care
Home Care
Skin Care
Home and Personal Care – Oral Care Oral Care
Mid Single Digit
toothpast
Toothpaste and Toothpowder both recorded growth in mid single digit.
Remove
Kids
Herb’l range continued to deliver robust performance.
Home and Personal Care – Hair Care Hair Care
High Teens
Hair oils reported a high teens growth rate driven by double digit
growth in both perfumed and coconut oils
Shampoo segment also report a high teens growth rate.
Home and Personal Care – Home Care Home Care
Double Digit
1 Odonil grew double-digit driven by strong growth momentum in Aerosols and gel pockets
Odomos and Sanifresh performed well with Odomos growing in mid-single digit and Sanifresh growing in
double digit.
Newly launched Odonil Car Fresheners and automatic diffusers have received positive response and
gained strong traction.
Home and Personal Care – Skin Care & Salon Skin Care
High Single Digit
1 Skin care growth was backed by strong growth in Oxy Franchise.
The recently launched Oxylife Detan has received positive consumer feedback.
Health
Supplements
Digestives
Healthcare
OTC &
Ethicals
Healthcare – Health Supplements Health Supplements
Low Single Digit Decline
1 Dabur Chyawanprash grew by low single digit.
Honey declined mid-single digit on a high base,
2 partly impacted by temporary disruption in trade
sentiment following FSSAI labeling related order.
Healthcare – Digestives Digestives
Strong Double Digit
Hajmola franchise continued to perform well, recording double digit growth.
2 Pudin Hara posted strong double-digit growth, driven by growth across all formats.
Isabgol delivered strong double-digit growth, driven by improved market competitiveness.
Newly launched orange Isabgol added with ayurvedic actives received well among
consumers.
Healthcare – OTC & Ethicals OTC & Ethicals
Mid Teens
1 Dabur Honitus continued its strong growth momentum with broad based
growth across formats
2 Health Juices sustained their strong growth trajectory, registering
high-teen growth on a strong base
Beverage
Foods &
Beverage
Foods
Foods & Beverage – Beverages Beverages
Mid Teens
1 Beverages recorded a sequential improvement with mid teens growth.
Broad based growth with nectar growing at near double digit
and the Activ portfolio continuing the robust performance
with double digit growth.
Foods & Beverage – Foods
Foods
Strong double digit
Foods portfolio continued its strong growth momentum and reported strong double-digit growth with
broad-based growth across products.
Badshah also reported strong double-digit volume led growth.
Growth was supported by focused brand-building initiatives, enhanced consumer activations, and
increased investments across quick commerce.
International Business
-33.3%
(CC: -38.7%)
Namaste (US) Turkey
+21.2%
+42.4%
(CC: +11.5%)
(CC: +53.1%)
MENA Region
+13.7%
(CC: 3.8%)
Bangladesh
Egypt
+31.4%
+30.4%
(CC: +22.4%)
(CC: +25.8%)
Nigeria
+21.4%
(CC: -0.9%) SSA Region
+43.2%
(CC: +26.6%)
Note: The world map is for illustrative purposes only, is not drawn to scale, and does not represent the accuracy or authenticity of geographical or political boundaries
03 Brand
Communication
Communications – Impactful Brand Campaigns
Click on the video to play
Communications - Influencer Campaigns
Annexures
Profit & Loss Statements – Q2 & H1FY27 Consolidated P&L
Particulars
Q2 FY27 Q2 FY26 Y-o-Y (%) H1 FY27 H1 FY26 Y-o-Y (%)
In INR crores
Revenue from operations 3,563.1 3,191.3 11.6% 7,327.5 6,595.9 11.1%
Material Cost 1,822.7 1,613.5 13.0% 3,804.6 3,416.8 11.4%
Employee expense 376.8 347.9 8.3% 746.2 685.6 8.8%
Advertisement and publicity 226.6 233.6 (3.0%) 456.0 435.5 4.7%
Other Expenses 504.6 408.3 23.6% 946.8 802.1 18.0%
Operating Profit 632.5 588.1 7.5% 1,373.8 1,255.9 9.4%
% of Revenue 17.8% 18.4% (60 bps) 18.7% 19.0% (30 bps)
EBITDA (inc Other income) 804.3 728.2 10.5% 1,718.3 1,540.0 11.6%
% of Revenue 22.6% 22.8% (20 bps) 23.4% 23.3% 10 bps
Reported Net profit for the
505.5 452.6 11.7% 1,096.4 966.5 13.4%
period/year (after minority)
% of Revenue 14.2% 14.2% Flat 15.0% 14.7% 30 bps
Profit & Loss Statements – Q2 & H1FY27 Standalone P&L
Particulars
Q2 FY27 Q2 FY26 Y-o-Y (%) H1 FY27 H1 FY26 Y-o-Y (%)
In INR crores
Revenue from operations 2,432.9 2,234.8 8.9% 5,120.2 4,704.3 8
[Showing first 8,000 characters — download PDF for full document]